Introduction
The differentiation of hematopoietic stem cells (HSCs) into specific progenitor cells, and ultimately into diverse blood cell types, is intricately controlled by intercellular and intracellular signaling mechanisms (Kaushansky, 2006; Mikkola and Orkin, 2006) . These mechanisms commonly target transcriptional regulators, which in turn establish complex transcriptional networks. Dysregulation of signaling and transcriptional mechanisms leads to the development and progression of specific leukemias (Gilliland et al., 2004; Rosenbauer and Tenen, 2007) . Whereas the focus of this review is on transcriptional mechanisms that underlie red blood cell development, the process termed erythropoiesis, the fundamental principles emerging from these studies have broad relevance in diverse systems.
Since a host of transcriptional regulators and signaling pathways that control erythropoiesis have already been identified, major efforts are focused on elucidating the underlying molecular mechanisms. Canonical transcriptional mechanisms involve sequence-specific binding of trans-acting factors (transcription factors) to DNA motifs termed cis-elements in chromatin, followed by recruitment of additional regulatory proteins (coregulators) via direct protein-protein interactions (Kadonaga, 2004) . Coregulators typically exist as large multiprotein complexes and either mediate activation (coactivators) or repression (corepressors) Lee and Workman, 2007) . Certain coregulator complexes mediate both activation and repression in a contextdependent manner (Crispino et al., 1999; Rogatsky et al., 2002) . It is instructive to classify coregulators as chromatin remodeling or chromatin modifying enzymes, based on whether they lack or have the capacity, respectively, to post-translationally modify histones that form the octameric core of the nucleosome. Chromatin remodeling enzymes utilize ATP in a biochemical reaction that modifies nucleosome structure and alters nucleosome positioning (Saha et al., 2006) . Since chromatin can be a formidable impediment to transcription factor access to nucleosomal DNA (Hager et al., 1993) , remodeling enzymes regulate transcription factor access to chromatin. In addition, as nucleosomal filaments condense into higher-order structures (Felsenfeld and Groudine, 2003) , remodeling enzyme-dependent chromatin structure transitions almost certainly regulate higher-order chromatin folding.
In contrast to remodeling enzymes, chromatin modifying enzymes catalyse a plethora of histone posttranslational modifications, including acetylation, methylation, phosphorylation, ubiquitination, sumoylation and ADP ribosylation, which are termed epigenetic marks (Allfrey et al., 1964; Fischle et al., 2003) . Such modifications are particularly prevalent within the conserved N-terminal core histone tails, but also occur within the central globular domain (Berger, 2007; Bernstein et al., 2007; Kouzarides, 2007) . In certain cases, epigenetic marks regulate chromatin structure directly. For example, histone acetylation counteracts higher-order chromatin folding with purified, reconstituted chromatin templates in vitro (Tse et al., 1998) . In addition, specific epigenetic marks function as ligands to attract additional regulatory factors to the chromatin (Marmorstein, 2001; Fischle et al., 2003) . Protein modules present in transcriptional regulatory factors, including the bromodomain that recognizes acetyl-lysine (Dhalluin et al., 1999; Jacobson et al., 2000; Owen et al., 2000) , bind histones bearing specific epigenetic marks.
In addition to the canonical mechanisms noted above, certain transcription factors retain functionality upon disabling their sequence-specific DNA binding activity, indicating the importance of DNA binding-independent mechanisms in certain contexts (Reichardt et al., 1998; Porcher et al., 1999; Tuckermann et al., 1999) . Given that transcriptional complexes assembled at promoters and distal regulatory elements, such as enhancers and locus control regions (LCRs), often contain a large cohort of factors that engage in a multitude of proteinprotein interactions Dean, 2006) , it seems reasonable that certain transcription factors can integrate into such complexes without a critical DNA binding activity requirement. Such tethering might also permit stable transcription factor interactions at lowaffinity motifs, which otherwise would not be occupied. However, considerably less is known about transcription factor tethering mechanisms vs DNA bindingdependent mechanisms.
Important principles underlying transcriptional control in higher eukaryotes have regularly emerged from mechanistic studies on the regulation of the b-like globin gene cluster, a commonly used model system to elucidate cell type-specific and developmental-stage specific transcriptional mechanisms (Bank, 2006; Bresnick et al., 2006) . Studies with this system have led to multiple seminal discoveries including (1) the concept of an LCR, a transcriptional regulatory element that activates a linked gene proportional to template copy number and independent of the chromosomal integration site (Forrester et al., 1987; Grosveld et al., 1987) ; (2) identification of the founding member of the GATA transcription factor family (GATA-1), which regulates the development of specific blood cell lineages (Evans and Felsenfeld, 1989; Tsai et al., 1989) ; (3) identification of a novel chromatin insulator element (chicken hypersensitive site 4 (HS4)) (Chung et al., 1993) , which is efficacious as a biotechnology tool in gene therapy vectors and various expression cassettes (Emery et al., 2000 (Emery et al., , 2002 Puthenveetil et al., 2004) ; (4) the demonstration that cell-and tissue-specific chromatin domains can be characterized by broad regions of enhanced sensitivity to DNaseI, which is considered to be a hallmark of unfolded chromatin domains (Hebbes et al., 1988; Litt et al., 2001) ; and (5) the demonstration that cell-and tissue-specific active chromatin domains can have discontinuous histone modification patterns in which irregularly distributed epigenetic marks associated with active or repressed chromatin delineate functional subdomains (Forsberg et al., 2000b; Kiekhaefer et al., 2002; Bulger et al., 2003) .
Recent work with the b-globin system has provided important insights into perhaps the most fundamental aspect of transcriptional control, how trans-acting factors recognize and occupy functional sites in chromatin . cis-elements that mediate transcription factor binding to chromatin are typically short sequence motifs of 5-10 base pairs, and such motifs occur at a high frequency throughout genomes, simply based on the statistical distribution of nucleotides. The development of the chromatin immunoprecipitation (ChIP) assay to measure protein occupancy at endogenous chromatin sites in living cells has provided a powerful technology for analysing how transcription factors select functional sites in the genome (Orlando et al., 1997; Johnson and Bresnick, 2002; Im et al., 2004; Kirmizis and Farnham, 2004) .
Extensive analyses of chromatin occupancy by the hematopoietic zinc-finger protein GATA-1, which is discussed below in detail, revealed that only a small fraction of high-affinity GATA motifs are occupied in chromatin (Johnson et al., , 2007 Grass et al., 2003 Grass et al., , 2006 Pal et al., 2004b; Im et al., 2005; Martowicz et al., 2005) . Intriguingly, the cell type-specific coregulator Friend of GATA-1 (FOG-1), which mediates certain biological functions of GATA-1 (Tsang et al., 1997 (Tsang et al., , 1998 , facilitates GATA-1 occupancy at certain, but not all, chromatin target sites (Letting et al., 2004; Pal et al., 2004a) . We refer to this FOG-1 activity as chromatin occupancy facilitator (COF) activity. Thus, mechanisms responsible for the selective recognition of a small subset of motifs represent a crucial primary mode of transcriptional control, and specific protein-protein interactions influence this decision-making process. Subsequent to transcription factor occupancy of chromatin, a multitude of regulatory events, including coregulator recruitment, coregulator-dependent chromatin structure transitions, dynamics of transcription factor and coregulator interactions with the template, and interactions between these components and RNA Polymerase II (Pol II) dictate the magnitude and kinetics of the transcriptional response.
Transcriptional control at endogenous loci in higher eukaryotes requires numerous cell type-specific transcription factors, and therefore, not surprisingly, multiple factors are implicated in regulating b-like globin gene transcription (Bank, 2006; Bresnick et al., 2006) . Studies in cells genetically modified to lack specific factors have revealed that individual factors can have crucial non-redundant functions (Lu et al., 1994; Weiss et al., 1997; Coghill et al., 2001) . Despite these examples of non-redundant function, transcription factors often share a limited number of broadly expressed coregulators. Even though broadly expressed coregulators mediate transcriptional control of a plethora of genes in diverse cell and tissue types, three such coregulators, the protein/histone acetyltransferase CREB-binding protein (CBP)/p300 (Chrivia et al., 1993; Arias et al., 1994) , the thyroid hormone receptor-associated protein 220 (TRAP220) component of the 'Mediator' complex (Ito et al., 2000) , and the Brahma-related gene1 (BRG1) component of the SWI/SNF remodeling complex (Khavari et al., 1993) are crucial for erythropoiesis and are discussed below in detail.
A major challenge in dissecting transcriptional mechanisms that choreograph cellular differentiation is to understand the basis for context-dependent mechanistic permutations operational at distinct loci and at a single locus during different stages of differentiation. The organization of a cis-element near one or more additional cis-elements in a specific architecture yields a composite motif, which represents an important component of context-dependent transcriptional mechanisms. This common regulatory mode diversifies the spectrum of cell type-specific transcriptional outputs achieved by a finite number of factors. Subsequent to reviewing several important transcription factors and coregulators that control erythropoiesis, emerging mechanisms and principles will be discussed, specifically chromatin target site selection, mechanistic permutations that diversify factor functionality, the role of composite elements in combinatorial control, similar and distinct functions of transcription factor family members, novel coregulator mechanisms, and Pol II function at extragenic sites.
Transcription factors that control erythropoiesis: a brief primer

GATA-1
Following the recognition that a common sequence motif [(A/T)GATA(A/G)] (GATA motif) exists within transcriptional regulatory regions at most, if not all, erythroid cellspecific genes (Evans et al., 1988; Reitman and Felsenfeld, 1988) , a dual zinc-finger transcription factor, GATA-1, that binds this motif (Ko and Engel, 1993; Merika and Orkin, 1993) was purified and cloned (Evans and Felsenfeld, 1989; Tsai et al., 1989) . This founding member of the GATA transcription factor family is expressed in erythroid, megakaryocytic, eosinophil, and mast cell lineages (Cantor and Orkin, 2005) . Targeted disruption of Gata1 in mice provided evidence for its essential function in stimulating erythropoiesis (Pevny et al., 1991 (Pevny et al., , 1995 Simon et al., 1992; Weiss et al., 1994) . GATA-1 arrests cellular proliferation (Rylski et al., 2003; Munugalavadla et al., 2005) , and GATA-1-mediated survival of erythroid precursors involves induction of Bcl-xL expression (Weiss and Orkin, 1995; Gregory et al., 1999) .
The C-terminal GATA-1 zinc finger recognizes GATA motifs (Martin and Orkin, 1990) , whereas the N-terminal zinc finger stabilizes DNA binding at certain palindromic motifs (Trainor et al., 1996) . The N-terminal finger also directly binds FOG-1 (Crispino et al., 1999) and TRAP220 (Stumpf et al., 2006) (Figure 1 ). GATA-1 also binds CBP/p300 (Blobel et al., 1998) and several transcription factors including PU.1 (Rekhtman et al., 1999; Nerlov et al., 2000) , Sp1 (Merika and Orkin, 1995) and erythroid Kruppel-like factor (EKLF) (Merika and Orkin, 1995) ; (Figure 1) . Furthermore, proteomics analysis of GATA-1 interactors identified diverse GATA-1-containing multiprotein complexes (Rodriquez et al., 2005) .
Analyses of GATA-1 function, specifically to elucidate mechanisms underlying chromatin target site selection, transcriptional regulatory activity, and proteinprotein interaction logic have been greatly facilitated by the development of a facile genetic complementation assay. G1E cells were derived from Gata1-targeted mouse embryonic stem cells and have been engineered to stably express a ligandactivated estrogen receptor hormone-binding domain fusion to GATA-1 (ER-GATA-1) (Gregory et al., 1999) . In response to estradiol or tamoxifen, G1E-ER-GATA-1 cells differentiate from proerythroblast-like cells to a more mature phenotype. Transcriptional profiling provided evidence that the G1E system recapitulates a normal window of erythropoiesis (Welch et al., 2004) . Furthermore, the ER-GATA-1 chromatin occupancy pattern is indistinguishable from that of endogenous GATA-1 in mouse erythroleukemia (MEL) cells Im et al., 2005) and in human embryonic stem cell-derived erythroid cells (unpublished), further justifying the use of G1E cells as a physiologically relevant system to dissect mechanisms regulating erythropoiesis.
Prior to the rise in GATA-1 expression during erythropoiesis, GATA-2 is expressed in certain hematopoietic precursors, including HSCs (Tsai et al., 1994; The amino-terminal (N) zinc finger of GATA-1 binds FOG-1, TRAP220 and Sp1, whereas the C-terminal zinc finger binds PU.1, CBP/ p300 and EKLF. Evidence for binding is described in the following studies: Crispino et al. (1999) Orkin, 1997; Minegishi et al., 1999) . GATA-2 is crucial for the survival and proliferation of HSCs (Tsai et al., 1994; Tsai and Orkin, 1997) . Studies in G1E cells revealed that, in the absence of GATA-1, GATA-2 occupies conserved regulatory sequences dispersed over B80 kb of its own locus, and as GATA-1 levels rise, GATA-1 displaces GATA-2 from these sites (Grass et al., , 2006 Martowicz et al., 2005) . This 'GATA switch' is tightly coupled to Gata2 repression and also occurs during murine embryonic stem (ES) cell differentiation into erythroid cells (Lugus et al., 2007) . As FOG-1 facilitates GATA switches (Pal et al., 2004a) , it is attractive to propose that GATA switches are an important component of the repression mechanism. Whereas the precise mechanism by which FOG-1 facilitates GATA switches is unclear, studies with a GATA-1 mutant defective in FOG-1 binding (V205G) and in FOG-1-null cells revealed COF activity at certain chromatin sites (Letting et al., 2004; Pal et al., 2004a) . Upon engaging FOG-1, GATA-1 might acquire a competitive advantage for chromatin occupancy at GATA-2-bound chromatin sites. Thus, FOG-1-dependent GATA switches at Gata2 and additional loci might represent an important process driving erythropoiesis .
Once GATA switches at the Gata2 locus occur, how does GATA-1 instigate Gata2 repression? Whereas fundamental biochemical differences between GATA-1 and GATA-2 are not established, Gata2 repression is dependent on FOG-1. Analysis of GST-FOG-1 interactions with proteins in MEL cell nuclear extracts identified the nucleosome remodeling and histone deacetylase (NuRD) complex , which mediates transcriptional repression and chromatin remodeling (Ayer, 1999; Zhang et al., 1999b) . The N-terminal repression domain of FOG-1, and also that of FOG-2 (Lin et al., 2004) , which functions in the cardiovascular system (Svensson et al., 1999; Tevosian et al., 1999 Tevosian et al., , 2000 Crispino et al., 2001) , binds the NuRD complex containing Mi-2b (CHD4), RbAp46, RbAp48, MTA-1, MTA-2, p66, histone deacetylase 1 and histone deacetylase 2 subunits . The FOG-1-NuRD complex persists over multiple purification steps, indicative of a high stability in vitro . Components of the NuRD complex occupy several GATA-1 target genes including c-Myc, c-Myb, Gata2 and Tac-2 in vivo Johnson et al., 2006) . Whether GATA-2 differs from GATA-1 in its capacity to recruit and utilize the FOG-1-NuRD complex at the Gata2 locus is unknown. Nevertheless, NuRD components and GATA-1 occupancy at GATA-1 target genes do not strictly correlate Johnson et al., 2006) , and therefore either additional corepressors are crucial for repression or NuRD complex activity is regulated post-recruitment.
In contrast to GATA-1-mediated Gata2 repression, GATA-1 activates many genes, including the adult b-like globin gene bmajor. In G1E cells, GATA-1 recruits Pol II to the bmajor promoter . As LCR-bound Pol II can precede promoterbound Pol II (Johnson et al., 2001 (Johnson et al., , 2003 , it is likely that Pol II has functions at or near the LCR prior to promoter activation. Such functions might include longrange Pol II transfer, in which the LCR provides Pol II to the promoter (Johnson et al., 2001) , transcription-dependent chromatin remodeling (Travers, 1999) or generation of functional intergenic transcripts (Gribnau et al., 2000) . Subsequent to the report of Pol II occupying the LCR prior to bmajor activation (Johnson et al., 2001) , other examples emerged, in which Pol II occupancy of distal regulatory regions precedes activation (Szutorisz et al., 2005b) .
While the function of LCR-bound Pol II is not yet established, kinetic analyses in G1E-ER-GATA-1 cells, graded activation of ER-GATA-1 by titrating estradiol, and comparison of locus structure/function in G1E-ER-GATA-1 cells cultured at 37 vs 25 1C provided important insights into the multistep activation mechanism (Im et al., 2005; Kim et al., 2007) . These experiments revealed that GATA-1 occupies the LCR prior to the promoter. An LCR subcomplex also assembles prior to promoter complex assembly and establishment of a chromatin loop, which increases the proximity of the LCR relative to the adult b-like globin gene promoters .
High-affinity GATA motifs are scattered throughout the locus (Im et al., 2005) , and therefore the mere presence of such motifs is insufficient to determine the preferential LCR vs promoter occupancy. Of potential relevance to the preferential LCR occupancy, GATA-1 target genes are differentially sensitive to changes in GATA-1 levels/activities . Thus, as GATA-1 levels rise during erythropoiesis, one would predict that distinct subsets of target genes will be activated, which has important implications for understanding the progression of events that culminate in red blood cell development. As GATA-1 mutations in megakaryoblastic leukemia result in truncation of the GATA-1 N terminus (Wechsler et al., 2002; Crispino, 2005) , and this short form of GATA-1 (Bourquin et al., 2006) and a larger N-terminal deletion , have reduced transactivation activity, it is attractive to propose that genes requiring maximal GATA-1 levels are preferentially dysregulated by the leukemogenic GATA-1 mutant.
GATA-1 is subject to multi-site phosphorylation (Crossley and Orkin, 1994; Zhao et al., 2006) and acetylation (Boyes et al., 1998; Hung et al., 1999) , and such modifications could obviously contribute to key steps in GATA-1 function. However, the role of phosphorylation in regulating GATA-1 activity has been elusive, as a triple phosphorylation site mutant has indistinguishable activity vs wild-type GATA-1 in vivo (Rooke and Orkin, 2006) .
We have discussed GATA factor mechanisms independent of additional hematopoietic transcription factors, but GATA-1 engages in important functional interactions with other transcription factors, which need to be considered. For example, the GATA-1 interaction with PU.1, a member of the Ets family of transcription factors (Klemsz et al., 1990) illustrates such an interaction. PU.1 is expressed predominantly in blood cells and is required for the development of hematopoietic progenitor cells into B and T lymphocytes, monocytes and granulocytes (Hromas et al., 1993; Scott et al., 1994; McKercher et al., 1996) . By contrast, PU.1 blocks erythropoiesis (Schuetze et al., 1992 (Schuetze et al., , 1993 , and this repressive activity interfaces with GATA-1-dependent transcriptional mechanisms.
The Ets domain of PU.1 binds the C-terminal zinc finger of GATA-1 (Rekhtman et al., 1999; Liew et al., 2006) and antagonizes GATA-1 DNA binding (Zhang et al., 1999a (Zhang et al., , 2000 . PU.1 also inhibits CBP/p300-mediated acetylation of GATA-1 (Hong et al., 2002) . As a GATA-1 mutant lacking acetylation sites is impaired in occupying chromatin target sites in vivo (Lamonica et al., 2006) , inhibition of GATA-1 acetylation might underlie PU.1-mediated repression of GATA-1 activity. PU.1-mediated inhibition of erythropoiesis involves recruitment of a corepressor complex, consisting of retinoblastoma protein (pRb) (Rekhtman et al., 2003) , histone methyltransferase, Suv39H and heterochromatin protein 1a, to create a repressive chromatin structure at GATA-1 target genes, at least in certain contexts (Stopka et al., 2005) . Given the functional importance of the PU.1-GATA-1 interaction, and the balance between GATA-1 and GATA-2 levels, an important determinant of GATA switches, it will be crucial to develop assays to quantitate the absolute levels and specific activities of these factors, as well as their affinities for targets (protein-protein and protein-chromatin interactions) in primary hematopoietic precursors during development. In aggregate, this will allow one to model how differentiation stage-specific changes in the levels and activities of these factors reconfigure transcriptional networks that drive erythropoiesis. EKLF Differential cloning in the MEL cell system led to the identification of a novel erythroid cell-specific cDNA encoding a Kruppel-like transcription factor (KLF), which was designated as EKLF (Miller and Bieker, 1993) . EKLF binds CACCC motifs, analogous to other KLFs that have diverse roles during cellular differentiation and development (Bieker, 2001) . The targeted disruption of Eklf in mice demonstrates that EKLF is crucial for erythropoiesis and for adult b-like globin gene transcription (Nuez et al., 1995; Perkins et al., 1995) . Whereas EKLF was initially considered to solely regulate definitive erythropoiesis (Nuez et al., 1995) , recent work has demonstrated that EKLF also promotes primitive erythropoiesis (Hodge et al., 2006) . Transcriptional profiling studies of Eklf À/À fetal liver and ER-EKLF-expressing EKLF-null cells revealed that EKLF regulates diverse genes, including those encoding heme biosynthesis enzymes and cytoskeletal proteins (Drissen et al., 2005; Hodge et al., 2006; Nilson et al., 2006; Pilon et al., 2006) . Whether the bulk of these genes are direct EKLF targets is unknown.
EKLF is an important determinant of hemoglobin switching (Donze et al., 1995; Perkins et al., 1996; Wijgerde et al., 1996; Gillemans et al., 1998) . EKLF occupies HS1-HS3 of the b-globin LCR and the bmajor promoter in G1E-ER-GATA-1 cells (Im et al., 2005) . In primitive and definitive erythroid cells from E10.5 murine yolk sac, E14.5 fetal liver and Ter119 þ bone marrow, EKLF also occupies HS1-HS4 and the b-like globin promoters in a differentiation stage-specific manner, and EKLF levels differ in primitive vs definitive cells . The gene disruption results, analyses with EKLF mutants, and EKLF occupancy at the endogenous b-globin locus provide strong evidence that EKLF is an essential regulator of adult b-like globin gene regulation.
EKLF-interacting coregulators include CBP/p300, (Zhang et al., 2001 ) and BRG1 (Armstrong et al., 1998; Tewari et al., 1998; Brown et al., 2002) . Targeted disruption of Eklf abrogates DNaseI hypersensitivity at HS3 and the b-globin promoter , indicating that EKLF induces complex assembly at these sites, and analogous to conventional transcription factors, regulates chromatin structure (Armstrong et al., 1998) . EKLF resembles GATA-1 and FOG-1 is promoting the formation of a higher-order chromatin loop at the b-globin locus (Drissen et al., 2004) . EKLF also functions as a transcriptional repressor by recruiting Sin3A and histone deacetylase 1 Bieker, 2001, 2004 ). It will be crucial to determine the relative importance of EKLF activating vs repressing functions in regulating the b-like globin genes and in promoting both primitive and definitive erythropoiesis.
p45/NF-E2
The tandem AP-1-like motifs within HS2 of the b-globin LCR confer exceptionally strong, erythroid cell-specific enhancer activity in transfection assays (Mignotte et al., 1990; Moi and Kan, 1990; Ney et al., 1990a, b; Moon and Ley, 1991) . Studies to elucidate the molecular basis of this activity led to the discovery of the heterodimeric transcription factor nuclear factor-erythroid 2 (NF-E2). NF-E2, which consists of a hematopoietic-specific subunit, p45/NF-E2 (Ney et al., 1993; Andrews et al., 1993a) , and a member of the small Maf protein family (Andrews et al., 1993b) , is expressed in erythroid and megakaryocytic cells. Despite the enhancer activity mediated by NF-E2-binding sites, targeted disruption of p45/NF-E2 in mice did not appear to significantly perturb erythropoiesis or b-globin transcription. Rather, these studies demonstrated that p45/NF-E2 is crucial for megakaryopoiesis (Shivdasani and Orkin, 1995; Shivdasani et al., 1995b) .
Paradoxically, CB3 murine erythroleukemia cells, which lack p45/NF-E2 expression due to retroviral insertion within the p45/NF-E2 locus, do not express bmajor, and p45/NF-E2 expression reactivates bmajor expression (Lu et al., 1994; Kotkow and Orkin, 1995; Bean and Ney, 1997; Mosser et al., 1998; Kiekhaefer et al., 2004) . Endogenous p45/NF-E2 occupies the LCR, and to a lesser extent, the bmajor promoter in erythroid cells (Daftari et al., 1999; Forsberg et al., 2000a; Johnson et al., 2001; Sawado et al., 2001; Im et al., 2005) . The finding that Pol II occupies the LCR, but not the bmajor promoter, and p45/NF-E2 expression rescues Pol II occupancy at the promoter in CB3 cells, led to the model that p45/NF-E2 induces long-range Pol II transfer, resulting in considerably more Pol II at the promoter and transcriptional activation (Johnson et al., 2001) . Moreover, Pol II occupancy at the promoter decreased 30-40% in p45/NF-E2-null mice, whereas Pol II occupancy at the LCR remained unchanged (Kooren et al., 2007) . Biochemical analysis supports the feasibility of long-range Pol II transfer (Vieira et al., 2004) .
Analogous to GATA-1 and EKLF, p45/NF-E2 also binds CBP/p300. CBP/p300-mediated acetylation of the p45/NF-E2 heterodimeric partner MafG enhances NF-E2 DNA binding activity (Hung et al., 2001) . Unlike GATA-1 and EKLF, the b-globin locus in E14.5 fetal liver from wild-type and p45/NF-E2-null mice exhibits the chromatin loop, in which the bmajor promoter resides in proximity to the LCR (Kooren et al., 2007) . This analysis revealed an B35% reduction in bmajor transcription, and as noted above, 30-40% less Pol II occupancy at the promoter in E14.5 fetal livers of mutant mice.
p45/NF-E2 contains two PPXY motifs within its Nterminal activation domain, which bind certain WW domains in vitro and are required for activation of endogenous bmajor in CB3 cells (Mosser et al., 1998; Kiekhaefer et al., 2004) . Whereas the Yes-associated protein (Yagi et al., 1999) and transcriptional coactivator with PDZ-binding motif (Kanai et al., 2000) coregulators are WW domain-containing proteins, the endogenous WW domain partner of p45/NF-E2 is unknown.
p45/NF-E2-mediated transactivation in a chromatin context is enhanced by mitogen-activated protein kinase signaling (Versaw et al., 1998; Forsberg et al., 1999b) . Furthermore, lysine 368 and serine 169 of p45/NF-E2 are sumoylated and phosphorylated, respectively, and both modifications are important for bmajor transcriptional activation in CB3 cells (Casteel et al., 1998; Shyu et al., 2005) .
The p45/NF-E2 occupancy at the endogenous b-globin locus in erythroid cells, the p45/NF-E2-dependence for bmajor transcription in CB3 cells, and the significant decreases in Pol II occupancy at the bmajor promoter and bmajor transcription in p45/NF-E2 knockout mice indicate that NF-E2 is an important regulator of hemoglobin synthesis. The lack of a large defect in b-like globin expression in p45/NF-E2-null mice might be related to the existence of NF-E2-related factors, such as NF-E2-related factors 1 and 2 (Nrf1 and Nrf2) (Chan et al., 1993 (Chan et al., , 1996 Caterina et al., 1994) or Bach1 and Bach 2 (Igarashi et al., 1998) . However, p45/NF-E2-Nrf2 double knockout mice do not exhibit a more severe erythroid phenotype than p45/NF-E2-null mice (Martin et al., 1998) . Alternatively, compensatory mechanisms in the mutant mice might suppress the magnitude of a b-like globin gene expression defect.
SCL (TAL-1)
Coincident with the purification and cloning of GATA-1, studies on mechanisms underlying T-cell acute lymphoblastic leukemia led to the discovery of a transcription factor, stem cell leukemia (SCL) or T-cell acute lymphocytic leukemia-1, which functions at multiple stages of hematopoiesis (Begley et al., 1989a (Begley et al., , b, 1991 Aplan et al., 1990a, b) . SCL is a member of the basic helix-loop-helix family of transcription factors, which dimerize with other E-proteins (for example, E47) and bind E-box motifs (CANNTG) (Begley et al., 1989b; Chen et al., 1990) . Mice lacking SCL are incapable of generating red blood cells in the yolk sac, and Scl À/À ES cells fail to give rise to hematopoietic cells (Robb et al., 1995; Shivdasani et al., 1995a; Porcher et al., 1996) . SCL has important functions to stimulate the generation of hemangioblasts, which differentiate into both blood and endothelial cells (Chung et al., 2002; Ema et al., 2003; Gering et al., 2003; Patterson et al., 2007) . SCL is required to generate HSCs, although conditional knockout analysis indicates that SCL is not required for HSC function (Mikkola et al., 2003) .
In addition to heterodimerizing with an E-protein partner, SCL can exist as a multiprotein complex consisting of LMO2, E47, Ldb1 and GATA-1 (Wadman et al., 1997) . This complex is found in cells representing different stages of erythropoiesis (Vyas et al., 1999; Xu et al., 2003; Anguita et al., 2004; Brand et al., 2004; Lahlil et al., 2004) . DNA site selection studies indicated that the SCL complex preferentially binds a composite motif consisting of a GATA motif and a neighboring E-box (Wadman et al., 1997) , which is implicated in mediating SCL actions at distinct stages of hematopoiesis.
The Ldb1 component of the SCL complex interacts with single-stranded DNA-binding proteins, which appear to be important regulators of SCL function (Chen et al., 2002; Xu et al., 2007) . Single-stranded DNAbinding protein 2 increases steady-state levels of endogenous Ldb1 and LMO2, GATA-E-box DNA binding activity, and facilitates expression of a direct target of the GATA-E-box-binding complex Protein 4.2 (P4.2) in erythroid precursor cells (Xu et al., 2007) . Proteomic studies identified Eto-2 and cyclin-dependent kinase Cdk9 as Ldb1-interacting proteins (Meier et al., 2006) . Ldb1 forms multiple complexes during erythroid differentiation, and morpholino-dependent knockdown of these components in zebrafish revealed that they are essential for definitive hematopoiesis (Meier et al., 2006) . SCL activity is regulated via standard mechanisms involving post-translational modifications and interactions with coregulators, although many questions remain unanswered regarding the precise mechanisms. SCL phosphorylation increases DNA binding activity (Prasad et al., 1995; Prasad and Brandt, 1997) , while SCL acetylation mediated by CBP/p300 (Huang et al., 1999) and p300/CBP-associated factor appears to be required for transactivation. SCL transactivation activity is inhibited by an mSin3A-and histone deacetylase 1/2-containing corepressor complex Xu et al., 2006) , and BRG1 overexpression increases occupancy of this complex at the P4.2 promoter (Xu et al., 2006) .
Although canonical transcriptional mechanisms involve sequence-specific DNA binding activity of transcription factors, SCL mutants defective in DNA binding rescue hematopoiesis from Scl À/À murine embryonic stem cells (Porcher et al., 1999) . Thus, SCL DNA binding activity might be dispensable in certain contexts. Given the apparent SCL complex heterogeneity, regulation via multiple post-translational modifications, the novel non-DNA binding function, and functions early in hematopoiesis to generate hemangioblasts and to regulate HSC function, as well as later during erythropoiesis, considerably more work is required to understand SCL structure/function.
Coregulators that control erythropoiesis
FOG-1
The nine-zinc-finger protein FOG-1 was identified by yeast two-hybrid screening with the zinc-finger DNAbinding domain of GATA-1 as bait (Tsang et al., 1997) . FOG-1 deficiency causes severe anemia and death during mid-embryonic development (Tsang et al., 1998) . As the expression of FOG-1 mimics that of GATA-1, FOG-1 exemplifies a cell type-specific coregulator, in contrast to the common broadly expressed coregulators. Unlike many protein-protein interactions, in which the functional relevance is assessed via correlative analyses, a rigorous approach using altered-specificity mutants of GATA-1 provided definitive evidence that the GATA-1-FOG-1 interaction is crucial for GATA-1-dependent erythropoiesis (Crispino et al., 1999) . Moreover, this same mutation in the N-terminal finger of GATA-1 was detected in patients with familial dyserythropoietic anemia and thrombocytopenia (Nichols et al., 2000) .
Despite the established FOG-1 function to mediate important GATA-1 activities, molecular mechanisms underlying FOG-1-dependent transcriptional activation and repression are poorly understood. FOG-1 facilitates GATA-1 chromatin occupancy at certain chromatin sites (Letting et al., 2004; Pal et al., 2004a) and is required for GATA switches (Pal et al., 2004a) . Thus, FOG-1 coactivator activity might solely involve facilitated GATA-1 chromatin occupancy. FOG-1 also facilitates GATA-1-mediated looping that brings the LCR in proximity to the adult b-globin genes . However, the FOG-1 requirement for looping might be secondary to FOG-1 facilitation of GATA-1 chromatin occupancy. FOG-1 interacts with transforming acidic coiled-coil protein 3, which regulates FOG-1 subcellular localization (Garriga-Canut and Orkin, 2004) . FOG-1 also binds the corepressor C-terminal-binding protein (Fox et al., 1999) and the NuRD complex Johnson et al., 2006) . Knock-in mice expressing a FOG-1 mutant defective in C-terminal-binding protein binding revealed that the FOG-1-C-terminal-binding protein interaction is dispensable for erythropoiesis in vivo .
Many questions remain unanswered regarding mechanisms of FOG-1 function, including whether FOG-1 zinc fingers not involved in GATA-1 binding have specific functions, whether COF activity is the predominant means by which FOG-1 activates transcription, whether FOG-1 has novel biochemical activities that specifically regulate chromatin loop formation, and how the activation vs repression functions of FOG-1 are selectively utilized.
CBP/p300 CBP and its paralog p300 are acetyltransferases that acetylate histones and a plethora of non-histone proteins (Goldman et al., 1997; Mayr and Montminy, 2001) . Targeted disruption of Cbp in mice leads to embryonic death due to developmental retardation and multiple organ defects, including reduced numbers of primitive and definitive hematopoietic precursor cells and defective vasculogenesis (Yao et al., 1998; Oike et al., 1999; Kung et al., 2000) . Targeted gene disruption studies also provided evidence for a role of CBP, but not p300, in HSC self-renewal, whereas p300, but not CBP, is required for differentiation (Rebel et al., 2002) . Furthermore, CBP and p300 have distinct functions in T-cell lymphopoiesis (Kasper et al., 2006) . CBP/p300 physically and functionally interact with many transcription factors, including GATA-1, p45/NF-E2 and EKLF (Blobel et al., 1998; Zhang and Bieker, 1998; Forsberg et al., 1999a) . Studies with the CBP/p300 inhibitor adenoviral E1A provided evidence that CBP/ p300 facilitates GATA-1-mediated transcriptional activity and promotes erythroid differentiation (Blobel et al., 1998) . CBP acetylates GATA-1 (Hung et al., 1999) and increases NF-E2 DNA binding activity (Hung et al., 2001) . Studies with E1A also indicated that CBP/p300 is crucial for LCRmediated transactivation (Forsberg et al., 1999a) . CBP/ p300 acetylates EKLF, which enhances EKLF binding to the SWI/SNF complex (Zhang et al., 2001; Letting et al., 2003; Im et al., 2005; Kim et al., 2007) . GATA-1 recruits CBP/p300 at the LCR and bmajor promoters, and consistent with this result, GATA-1 increases histone H3 and H4 acetylation at these sites Letting et al., 2003; Im et al., 2005) . However, whether CBP/p300 are the principle acetyltransferases mediating these epigenetic events is unknown.
It has been proposed that the concentration of CBP/ p300 is limiting in certain cellular contexts, and therefore activation of one or more pathways that utilize CBP/p300 could in principle sequester CBP/p300 away from additional CBP/p300-dependent pathways (Kamei et al., 1996) . Thus, CBP/p300 might be crucial for establishing signaling crosstalk and/or transcriptional networks that drive erythropoiesis. It will be important to determine whether dynamic changes in CBP/p300 levels/activities occur during erythropoiesis, and whether such changes similarly or distinctly affect the activities of hematopoietic transcription factors.
TRAP220
Mediator is a broadly expressed coregulator complex that participates in transcriptional activation or repression by diverse transcription factors and functions by regulating recruitment of Pol II and the basal transcriptional machinery (Kornberg, 2005; Belakavadi and Fondell, 2006) . Targeted disruption of TRAP220 in mice, which encodes an important Mediator component, perturbs various physiological processes, including placental, cardiac, neural and hepatic development, which causes lethality during early gestation (Ito et al., 2000; Zhu et al., 2000; Crawford et al., 2002; Landles et al., 2003) . TRAP220 mutant embryos also exhibit abnormalities in megakaryocyte and erythroid differentiation (Crawford et al., 2002; Landles et al., 2003) . Hematopoietic precursor cells isolated from E10.5 TRAP220-deficient embryos fail to form erythroid burst-forming units-erythroid and colony-forming units-erythroid (Stumpf et al., 2006) . These hematopoietic defects appear to be related in part to perturbed GATA-1 function.
TRAP220 binds GATA factors (Crawford et al., 2002) , and the GATA-1 N-finger contacts TRAP220 (Stumpf et al., 2006) . TRAP220 enhances GATA-1-mediated transactivation in a transient transfection context (Stumpf et al., 2006) . As TRAP220 co-occupies numerous chromatin sites with GATA-1 (unpublished), TRAP220 might be a generally important GATA-1 coregulator.
Interestingly, different Mediator complexes exist, which can function distinctly (Uhlmann et al., 2007) . Accordingly, it will be important to determine whether all or a subset of Mediator components occupy GATA-1 target sites in chromatin, and whether Mediator subcomplexes function uniquely at different chromatin target sites. Finally, the biochemistry of how GATA-1 elects to utilize TRAP220, CBP/p300 and FOG-1, and whether these coregulators are utilized simultaneously, sequentially or in a context-dependent manner is entirely unclear.
BRG1
Transcriptional activation often requires ATP-dependent chromatin remodeling complexes, such as the SWI/ SNF complex (Saha et al., 2006) . SWI/SNF uses ATP to disrupt histone-DNA interactions, which can increase factor accessibility to nucleosomal DNA (Narlikar et al., 2002) . Chromatin remodeling and modifying mechanisms can be intricately linked. For example, histone acetylation favors retention of SWI/SNF on reconstituted chromatin in vitro (Hassan et al., 2001) .
Not surprisingly, the BRG1 catalytic subunit of the SWI/SNF complex is essential in developmental and physiological processes (Narlikar et al., 2002; Bultman et al., 2005; de la Serna et al., 2006) . As BRG1 occupies HS4, HS3, HS2 and the bmajor promoter at the endogenous b-globin locus, and GATA-1 increases BRG1 occupancy at a subset of these sites (Im et al., 2005) , SWI/SNF functions directly to regulate b-like globin gene expression. SWI/SNF is also implicated in regulating human g-to b-globin gene switching (O'Neill et al., 1999 (O'Neill et al., , 2000 Lopez et al., 2002) .
Although the precise mechanisms of how SWI/SNF functions at the b-globin locus are unresolved, BRG1 has been reported to associate with several factors implicated in b-like globin gene regulation. BRG1 exists in a MafK complex in MEL cells (Brand et al., 2004) , and also in a b-globin LCR-associated chromatin remodeling complex (LARC) (Mahajan et al., 2005) . LARC binds the HS2-Maf recognition element, occupies HS2 in K562 erythroleukemia cells, and has chromatin remodeling activity (Mahajan et al., 2005) . BRG1 also binds EKLF, and the SWI/SNF complex is required for EKLF-mediated transcriptional activation in vitro (Armstrong et al., 1998; Kadam et al., 2000) .
Early embryonic lethality has been a significant obstacle for analysing specific BRG1 functions in vivo (Bultman et al., 2000) . However, mice bearing a hypomorphic Brg1 allele, isolated via an ENU mutagenesis screen, survive until E14.5 (Bultman et al., 2005) . Embryos containing the hypomorphic allele exhibit a block in erythropoiesis, leading to anemia. BRG1 mutant erythroid progenitor cells fail to develop into polychromatic erythroblasts, resembling the loss of GATA-1 (Bultman et al., 2005) . Reduced BRG1 activity in E12.5 fetal livers from hypomorph embryos compromises Pol II and serine 5-phosphorylated Pol II occupancy at the bmajor promoter, but not at the LCR . These defects resemble those seen upon deletion of the b-globin LCR in mice (Sawado et al., 2003) , consistent with a model in which the LCR critically requires BRG1 to maximally recruit Pol II to the promoter. Alternatively, maximal BRG1 activity might be required for erythroid precursor cells to progress to a specific stage of erythropoiesis, in which full Pol II occupancy occurs. Nevertheless, the BRG1 hypomorphic mice represent a novel tool for dissecting the role of this chromatin remodeling component in erythropoiesis.
Emerging mechanisms and principles
Chromatin target site selection: exquisite discrimination among abundant transcription factor-binding motifs in the genome As indicated above, GATA-1 occupies a small subset of regions containing GATA motifs within endogenous chromatin domains, despite GATA motif abundance throughout the genome (Johnson et al., , 2007 Grass et al., 2003 Grass et al., , 2006 Pal et al., 2004b; Im et al., 2005; Martowicz et al., 2005) . Whereas it is unclear whether this exquisite discrimination among binding motifs can be extrapolated to unrelated transcription factors, based on the impact of chromatin on cis-element accessibility, it would not be surprising if stringent selection mechanisms are common. Of particular interest will be to determine whether factors recognizing considerably longer motifs that occur much less frequently in the genome also select a small subset of the motifs. Furthermore, as certain factors, such as the glucocorticoid receptor, have the capacity to interact with nucleosomal DNA, whereas other factors that bind naked DNA with exceedingly high affinity, such as nuclear factor-1 (K d ¼ 10 À12 M), lack this capacity (Pina et al., 1990; Archer et al., 1991; Hager et al., 1993) , parameters dictating whether a motif is accessible or not can be factor-specific.
With the application of chromatin immunoprecipitation-chip, in which chromatin immunoprecipitation samples are analysed on genomic microarrays (Kirmizis and Farnham, 2004; Huebert et al., 2006) , a vast amount of factor binding data is currently being accumulated. Thus, the development of chromatin target site selection rules, both factor-specific rules and those with broader applicability, will be forthcoming. Since chromatin target site selection represents a very early step in transcription factor function, defining these rules is of great importance. With respect to GATA factor function, we proposed a GATA recognition code in which the intrinsic features of GATA motifs, nearestneighbor cis-elements and the chromatin microenvironment are crucial . However, elucidating the relative importance of these parameters requires considerable additional experimental analysis.
Mechanistic permutations in transcriptional control: how many mechanisms can a single transcription factor utilize? GATA-1 utilizes FOG-1 to both activate and repress target genes (Crispino et al., 1999) . However, expression of ER-GATA-1(V205G), defective in FOG-1 binding, in G1E cells induces expression of heme-regulated eIF-akinase (HRI), Eklf, Fog1 and Tac-2 (Crispino et al., 1999; Johnson et al., 2006; Kim et al., 2007) . Furthermore, ER-GATA-1 expression in FOG-1-null hematopoietic precursors can activate certain GATA-1 target genes (Johnson et al., 2007) . Thus, GATA-1 can activate certain target genes in a FOG-1-independent manner. ER-GATA-1(V205G) represses several genes including lymphoblastic leukemia (Lyl1) and regulator of G-protein signaling 18 (Rgs18) in G1E cells, and ER-GATA-1 represses these genes in FOG-1-null cells (Johnson et al., 2007) . Thus, GATA-1 can also repress certain target genes in a FOG-1-independent manner. ER-GATA-1 and ER-GATA-1(V205G) activate Tac-2 expression in FOG-1-null and G1E cells, respectively , indicating that GATA-1 does not require FOG-1 for Tac-2 activation. However, as a function of the ER-GATA-1 residency time at a Tac-2 intronic regulatory element (Pal et al., 2004b) , ER-GATA-1 acquires the capacity to repress Tac-2, which requires FOG-1 . Interestingly, Tac-2 encodes a neurokinin-B precursor (Pal et al., 2004b) , and neurokinin-B acts on receptors expressed by endothelial cells to confer antiangiogenic activity in diverse systems . Thus, GATA-1 regulates transcription via FOG-1-dependent and -independent activation (Figures 2a and c) , FOG-1-dependent and -independent repression (Figures 2b and e), and FOG-1-independent activation coupled to FOG-1-dependent repression (Figure 2d ).
While the role of FOG-1 as a GATA-1 coregulator to stimulate erythropoiesis is established (Crispino et al., 1999) , whether GATA-1 has crucial FOG-1-independent physiological functions remains to be determined. Since FOG-1 facilitates GATA-1 chromatin occupancy at a subset of chromatin target sites (Letting et al., 2004; Pal et al., 2004a) , in principle, certain GATA-1-activated genes might be intrinsically FOG-1-independent, based on the specific chromatin configuration of their regulatory regions. Diverse nuclear receptor coregulators seem to be differentially utilized in different contexts (Perissi et al., 2004) , suggesting a similar mechanistic complexity. However, many studies with nuclear receptor coregulators rely upon transient transfection assays, and given the abundant copies of heterogeneous plasmid templates per cell, it will be important Transcriptional control of erythropoiesis S-I Kim and EH Bresnick to analyse these mechanisms at endogenous target genes with physiological levels of receptors and coregulators. As GATA target genes can differ significantly in their sensitivities to altered GATA-1 levels, which does not appear to correlate with FOG-1 dependency , it will be important to define the target gene sensitivity determinants. Such determinants are relevant to both chromatin target site selection and post-chromatin occupancy regulatory steps. Nevertheless, since GATA factor levels dynamically change during erythropoiesis , during the development of distinct hematopoietic lineages and in specialized non-hematopoietic cell and tissue types, including the heart and nervous system (Charron and Nemer, 1999; Molkentin, 2000) , it is essential to ascertain how changes in factor levels/activities translate into target gene transcriptional changes.
Mechanistic diversification via combinatorial regulation
Chromatin target site selection is predicted to be regulated in part by additional cis-elements in the neighborhood of GATA motifs. Such elements might regulate GATA factor occupancy or confer a competitive advantage post-GATA factor occupancy. An example of the former mechanism would be if factors binding to the neighboring motifs recruit coregulators that influence GATA motif accessibility, or if such factors physically interact with GATA factors, thereby influencing GATA factor conformation and potentially altering DNA binding affinity. An example of the latter mechanism would be if factors binding the neighboring cis-elements recruit coregulators that synergize with GATA factorrecruited coregulators.
GATA-Ets composite elements have been identified in megakaryocyte-specific regulatory regions (Lemarchandel et al., 1993) , the þ 19 Scl enhancer region (Gottgens et al., 2002) , and the Lyl1 proximal promoter region (Chan et al., 2007; Figure 3a) . Mutations in GATA and Ets motifs abolish Scl þ 19 enhancer activity (Gottgens et al., 2002) , and Lyl1 promoter activity (Chan et al., 2007) . GATA and Ets motifs are required for GATA-1-mediated activation of the megakaryocyte aIIB promoter (Wang et al., 2002) . Importantly, without the Ets motif, which binds the tissue-specific Ets factor Fli-1, GATA-1 represses the promoter. Thus, Ets motifs are an important determinant of context-dependent GATA factor activity.
DNA site selection experiments, using MEL cell nuclear extracts that contain GATA-1, revealed the assembly of a multiprotein complex, consisting of SCL, LMO2, E47, Ldb1 and GATA-1, on oligonucleotides containing a GATA motif and an adjacent E-box (Wadman et al., 1997) . While the GATA-E-box composite element is implicated in the activation of certain GATA-1 target genes (Vyas et al., 1999; Anderson et al., 2000; Lahlil et al., 2004; Khandekar et al., 2007; Wozniak et al., 2007; Xu et al., 2007) (Figure 3b ), the mechanism of the apparent synergism between GATA-1 and the additional factors, and whether other GATA factors share this mechanism are unknown.
Dissecting mechanisms underlying the enhancer activity of the þ 9.5 kb intronic GATA switch site of the Gata2 locus revealed a GATA-E-box composite element, which confers enhancer activity in primary human endothelial cells and erythroid precursor cell lines. Furthermore, this element activates a LacZ reporter gene in the vasculature of transgenic mouse embryos (Khandekar et al., 2007; Wozniak et al., 2007) and a subset of cells within E11.5 fetal liver (Wozniak et al., 2007) of E12.5 transgenic mouse embryos. Although the GATA-E-box motif is sufficient for enhancer activity in G1E cells, additional regulatory modules are required for enhancer activity in human endothelial cells (Wozniak et al., 2007) . These studies provide evidence that the combinatorial usage of GATA-E-box motif with additional regulatory modules is an important determinant of context-dependent GATA factor-mediated transcriptional regulation (Figure 3c ). It would not be surprising if multiple scenarios exist in which GATA motifs merge with additional cis-elements under stringent architectural constraints to yield composite elements. Studies to define such composite motifs, and importantly to define the underlying mechanisms, are in their infancy.
Transcription factor families: common vs distinct determinants of chromatin target site selection and post-chromatin occupancy function Transcription factors often exist in families based on sequence homology, and family members can have both (b) A GATA-E-box composite element, which assembles a multiprotein complex containing GATA-1, SCL and other factors, is implicated in activation of certain GATA-1 target genes. (c) The GATA-E-box composite element is sufficient for enhancer activity of the Gata2 þ 9.5 kb GATA switch site in erythroid precursor cells (G1E), whereas its enhancer activity in human endothelial cells requires additional regulatory modules (GATA-E-box combinatorial). SCL, stem cell leukemia.
overlapping and unique expression patterns. Family members often share DNA binding specificities, at least based on naked DNA binding assays. In the case of factors with overlapping expression in a specific target cell type, and those that do not function redundantly in all contexts (for example, GATA-1 and GATA-2), an underlying logic must dictate unique transcriptional outputs for individual family members. Elucidating such logic will require information on the absolute concentrations of the respective factors and an assessment of their specific activities, the latter posing serious experimental challenges. The discovery of GATA switches in which GATA-1 replaces GATA-2 from certain chromatin sites during erythropoiesis , provides a system to analyse how related factors function both similarly and distinctly. Since GATA-1 and GATA-2 function redundantly to confer survival and/or proliferation to primitive erythroblasts (Fujiwara et al., 2004) , but also function distinctly to regulate erythroid cell-specific genes in G1E cells Grass et al., 2003) , the cellular context dictates GATA factor subtype-specific actions. Although GATA-1 and GATA-2 share an almost indistinguishable DNA-binding domain, their N-and C-termini are considerably different, and therefore it would be not surprising if fundamental differences exist in their biochemical mechanisms of action. Identifying such differences has the potential to yield broad insights relevant to GATA factors and other transcription factor families.
Novel coregulator mechanisms: facilitation of chromatin occupancy and looping As discussed above, conventional coregulators function as chromatin remodeling or modifying enzymes, and in the case of Mediator, interact with Pol II and/or associated components. While FOG-1 binds the NuRD complex and is therefore associated with both chromatin remodeling and modifying activities , FOG-1 has the unique activity of facilitating GATA-1 chromatin occupancy at certain sites (Letting et al., 2004; Pal et al., 2004a) . This COF activity is likely relevant to its ability to promote GATA switches. Whether the COF activity requires the NuRD complex and/or other coregulators is unknown, as assays are not established to study FOG-1 function in cell free system. Furthermore, the genetic complementation assay in FOG-1-null cells is complex, as the cells do not respond synchronously to FOG-1 expression . Thus, considerable additional work is required to dissect mechanisms underlying COF activity. It will be instructive to consider whether the FOG-1 zinc fingers not involved in GATA-1 binding are important in this regard. As factors such as nuclear factor-1 (NF-1) cannot bind motifs within nucleosomal DNA, despite very high-affinity DNA binding activity (Pina et al., 1990; Archer et al., 1991) , one might predict that mechanisms in which coregulators facilitate chromatin occupancy by the interacting transcription factor are extremely useful in higher eukaryotic genomes.
Intriguingly, both GATA-1 and FOG-1 promote a higher-order chromatin structure transition, in which the proximity of the LCR relative to the bmajor promoter increases Kim et al., 2007) . Thus, GATA-1-mediated recruitment of FOG-1 might instigate or facilitate chromatin looping, or by virtue of its COF activity, FOG-1 might establish maximal GATA-1 occupancy, which would suffice for chromatin looping. While the exact mechanism is unknown, four zinc fingers of FOG-1 contact GATA-1, and disabling this protein-protein interaction requires mutational disruption of all four fingers Liew et al., 2005) . Although nothing is known about the stoichiometry of GATA-FOG-1 complexes in chromatin, FOG-1 and/or other GATA-1-bound coregulators might have the capacity to simultaneously interact with more than one GATA-1 molecule, for example, GATA-1 bound to dispersed sites. Alternatively, since histone acetylation can unfold chromatin (Forsberg and Bresnick, 2001 ), coregulator-dependent acetylation and the establishment of other epigenetic marks at strategic sites within a chromatin domain might serve as a primary step in loop formation. Of course, such a mechanism would not be mutually exclusive with mechanisms involving transcription factor or coregulator-dependent multivalent interactions.
Parameters governing chromatin loop formation are largely unknown, and therefore the relationship between such parameters and those relevant to DNA looping over short distances of a 1000 bp or less without chromatin (Schleif, 1992) , is unclear. Since entire chromatin domains cannot be reconstituted in vitro, and many components of such domains are not even known, it will be important to dissect the underlying mechanisms at endogenous loci using genetic and molecular approaches.
Pol II function at extragenic sites: a specialized or common mode of transcriptional control? While traditional transcriptional mechanisms focus on how activators and repressors utilize coregulators to regulate Pol II recruitment and function at promoters, a considerably more complex picture has emerged, whereby Pol II resides at regulatory regions of genes, often before it appears at the associated promoter. Evidence exists for intergenic transcription broadly throughout the genome (Kapranov et al., 2007) , and given the barrage of new insights regarding small RNA-based regulatory mechanisms (Chang and Mendell, 2007; Grewal and Elgin, 2007) , it is likely that intergenic transcripts provide precursors for the generation of regulatory RNA molecules. However, as Pol II complexes can contain coregulators that modify or remodel chromatin (Cho et al., 1998; Krogan et al., 2003a, b; Li et al., 2007) , the processive movement of Pol II along chromatin within an intergenic region might also serve to regulate chromatin structure independent of RNA generation (Travers, 1999) . Finally, delivery mechanisms have been proposed in which Pol II tracks along chromatin from a regulatory element to a promoter (Kong et al., 1997; Ling et al., 2004) , or Pol II bound to a distal regulatory element is brought into proximity of a promoter (Gribnau et al., 2000; Carter et al., 2002; Tolhuis et al., 2002; Vakoc et al., 2005; Kim et al., 2007) , which in principle would allow long-range Pol II transfer to the promoter (Johnson et al., 2001) .
Although evidence supporting the mechanisms noted above exist, studies to define Pol II function at intergenic sites are in their infancy. The challenge will be to devise innovative strategies to dissect mechanisms in the context of endogenous loci, rather than synthetic templates in which promiscuous Pol II access and function might occur. Given the presence of Pol II at certain distal regulatory elements prior to promoter activation (Szutorisz et al., 2005b; Bresnick et al., 2006) , developmental alterations in Pol II occupancy at such elements (Szutorisz et al., 2005a; Levings et al., 2006) , the requirement for cell type-specific transcription factors for Pol II recruitment to distal elements (Johnson et al., 2001 (Johnson et al., , 2003 Vieira et al., 2004; Szutorisz et al., 2005a) , and the compelling mechanistic possibilities, future work in this area promises to be rewarding vis-a`-vis elucidating the transcriptional control of erythropoiesis, and more broadly, transcriptional mechanisms that regulate diverse biological processes.
